www.okaybio.com
促甲状腺素受体抗体（TRAb）_TSHR抗体参考范围_Graves病诊疗指南汇总_...
本文对促甲状腺素受体抗体（TRAb）相关的甲亢、Graves病诊疗指南进行了汇总。 文章内容包括TSHR抗体参考范围及有意诊断界值、TSHR抗体与Graves病诊断标准、TRAb与胎儿和新生儿甲亢诊断、TRAb与Graves病诊疗方案的确定。
tshrab抗体3.88
Searching…
Web results
www.verywellhealth.com
Thyrotropin Receptor Antibody (TRAb) Test: Uses and Results
Oct 10, 2025 · Bulging eyes (called Graves' ophthalmopathy) 3 Skin lesions (called thyroid dermopathy), which cause swelling and severe itching
health.baidu.com
tshrab抗体偏高 | 百度健康·医学科普
TSHRAb（促甲状腺激素受体抗体）偏高提示甲状腺自身免疫异常，最常见于Graves病（毒性弥漫性甲状腺肿）。 该抗体可刺激甲状腺过度分泌激素，引发甲亢症状，需结合甲状腺功能、症状及影像学综合评估。
pmc.ncbi.nlm.nih.gov
Clinical Significance of Classification of Graves’ Disease ...
To elucidate the clinical significance of heterogeneity of TSHRAb in Graves’ disease, we measured stimulating TSHRAb activities with FRTL-5 cells, CHO-hTSHR cells, Mc1+2, and Mc 2 cells, blocking TSHRAb activities wit...
www.mayocliniclabs.com
THYRO - Overview: Thyrotropin Receptor Antibody, Serum
Recommended first-line test for detection of thyrotropin receptor antibodies Differential diagnosis of etiology of thyrotoxicosis in patients with ambiguous clinical findings and/or contraindicated (eg, pregnant or br...
www.tsu.tw
甲状腺自身抗体测定（检测） - 内分泌学 - 天山医学院
是一组针对不同抗原决定簇的多克隆抗体（IgG型为主），主要用于自身免疫性甲状腺病（autoimmune thyroid diseases，AITD）诊断。
zhuanlan.zhihu.com
甲状腺自身抗体（TGAB、TPOAB、TRAB）解读 [千麦医疗]
Jan 12, 2024 · 有些患者会疑惑，为什么我的甲状腺功能指标都正常，但是 甲状腺自身抗体高出正常值很多倍？ 今天我们就来探究一下甲状腺自身抗体的秘密。
www.labcorp.com
010314: Thyrotropin Receptor Antibody, Serum | Labcorp
McKenzie JM, Zakarija M. Clinical review 3: The clinical use of thyrotropin receptor antibody measurements. J Clin Endocrinol Metab. 1989 Dec; 69 (6):1093-1096.
ltd.aruplab.com
Thyroid Stimulating Hormone Receptor Antibody (TRAb)
Centrifuge and separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to an ARUP standard transport tube. (Min: 0.3 mL) Storage/Transport Temperature Preferred temperatures for storage pri...
health.baidu.com
tshrab在甲状腺诊断中的作用 | 百度健康·医学科普
TSHRAb属于自身免疫性抗体，直接作用于甲状腺细胞表面的促甲状腺激素（TSH）受体。 正常情况下，TSH通过与受体结合调节甲状腺激素分泌；而TSHRAb可模拟或阻断这一过程，引发甲状腺功能紊乱。